Systemic Delivery of a STING Agonist‐Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis
Small · 2023-10 · 19 (43)
DOI: 10.1002/smll.202300544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 28.06.2023. Verfasst von Eun-Jin Go und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi, 13496, Republic of Korea. Hauptthemen laut MEDLINE: Liposomes, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Although stimulator of interferon genes (STING) agonists has shown great promise in preclinical studies, the clinical development of STING agonist therapy is challenged by its limited systemic delivery. Here, positively charged fusogenic liposomes loaded with a STING agonist (PoSTING) are designed for systemic delivery and to preferentially target the tumor microenvironment. When PoSTING is administered intravenously, it selectively targets not only tumor cells but also immune and tumor endothelial cells (ECs). In particular, delivery of STING agonists to tumor ECs normalizes abnormal tumor vasculatures, induces intratumoral STING activation, and elicits robust anti‐tumor T cell immunity within the tumor microenvironment. Therefore, PoSTING can be used as a systemic delivery platform to overcome the limitations of using STING agonists in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi, 13496, Republic of Korea.
- Laboratory of Translational Immuno-Oncology, CHA University School of Medicine, Seongnam, Gyeonggi, 13496, Republic of Korea.
- Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Seoburo 2066, Suwon, Gyeonggi, 16419, Republic of Korea.
- Department of Biomedical Science, CHA University, Seongnam, Gyeonggi, 13496, Republic of Korea.
ORCID-Profile: Eun-Jin Go, Hannah Yang, Wooram Park, Won Suk Lee, Dong Keun Han, Hong Jae Chon, Chan Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Go, E. J., Yang, H., Park, W., Lee, S. J., Han, J. H., Kong, S. J., Lee, W. S., Han, D. K., Chon, H. J., & Kim, C. (2023). Systemic Delivery of a STING Agonist‐Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis. Small, 19(43). https://doi.org/10.1002/smll.202300544
Vancouver
Go EJ, Yang H, Park W, Lee SJ, Han JH, Kong SJ, et al. Systemic Delivery of a STING Agonist‐Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis. Small. 2023;19(43). doi:10.1002/smll.202300544
BibTeX
@article{Go2023,
author = {Go, Eun-Jin and Yang, Hannah and Park, Wooram and Lee, Seung Joon and Han, Jun-Hyeok and Kong, So Jung and Lee, Won Suk and Han, Dong Keun and Chon, Hong Jae and Kim, Chan},
title = {Systemic Delivery of a STING Agonist‐Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis},
journal = {Small},
year = {2023},
volume = {19},
number = {43},
doi = {10.1002/smll.202300544}
}
EUVIMED